Net Income

With $255M from star investors, a firm is betting on a radical idea: that treating employees with dignity is the best way to generate returns.

A Canadian-made prostate treatment wins a major innovation award as new U.S. Medicare reimbursement positions it for explosive market growth.

As a veteran leader retires after five years of growth, Husky Technologies brings in Tracy Cordes to spearhead a new era of service innovation.

A new oral drug, IMSB301, offers hope for Aicardi Goutières Syndrome, a devastating rare disease with no cure, in a pivotal new clinical trial.

Airia's new support for MCP Apps lets businesses embed live dashboards and forms in AI chats, transforming efficiency and eliminating AI hallucinations.

Clinical-stage biotech BioVie announces its novel anti-inflammatory drug, bezisterim, will be featured at a key psychiatric conference for its potential.

A new plant-derived drug shows promise in preventing prostate cancer and improving cholesterol, but the company faces significant financial hurdles ahead.

The iconic brand is pivoting from its print legacy to a diversified lifestyle empire, and it has a new plan to convince investors it's the right move.

Truist partners with Mastercard on a new API platform, giving clients more control over their data while navigating a complex regulatory and competitive landscape.

The casino giant posts a strong Q4 profit, reversing a prior year loss, as Macau's mass market boom and European expansion offset challenges in Manila.

Align Partners launches a major governance overhaul campaign at Dentium, aiming to fix the 'Korea discount' and unlock value at the undervalued market leader.

With promising new data for its cancer and obesity pipeline, Corbus Pharmaceuticals prepares for a crucial investor presentation at the Oppenheimer conference.

A landmark deal in the Andaman Sea unlocks vast natural gas reserves, aiming to secure Indonesia's energy future and redefine Southeast Asia's energy map.

A new study reveals HR burnout is pushing employers toward integrated, AI-powered benefit solutions, reshaping the future of workplace perks.

As population growth in high-risk areas drives storm damage to new records, experts reveal science-backed home upgrades that can save your property.

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

A new integrated test from NeoGenomics aims to slash diagnostic delays and streamline complex tumor profiling, promising faster, smarter cancer treatment.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

The snack giant outpaced the market in 2025 with its core brands, but projects a dip in 2026 earnings despite growth plans and a new buyback program.

Samsung's new HBM4 memory delivers unprecedented speed and efficiency, setting a new bar for AI and reshaping the competitive semiconductor landscape.